BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31189039)

  • 1. Cytoplasmic Blebs in T-Cell Prolymphocytic Leukemia.
    Abbas HA; Han X
    N Engl J Med; 2019 Jun; 380(24):2360. PubMed ID: 31189039
    [No Abstract]   [Full Text] [Related]  

  • 2. Case Study Interpretation--Houston: Case 4. T-cell prolymphocytic leukemia.
    Al-Quran SZ
    Cytometry B Clin Cytom; 2011; 80(4):264-8. PubMed ID: 21638771
    [No Abstract]   [Full Text] [Related]  

  • 3. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
    Fang H; Beird HC; Wang SA; Ibrahim AF; Tang Z; Tang G; You MJ; Hu S; Xu J; Li S; Yin CC; El Hussein S; Le N; Futreal PA; Bueso-Ramos C; Thakral B; Kadia TM; Thornton R; Little L; Gumbs C; Song X; Medeiros LJ; Wang W
    Leukemia; 2023 Sep; 37(9):1919-1921. PubMed ID: 37443196
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
    Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
    Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X; Cherian S
    Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear nonpalpable purpura in a young male: a unique presentation of leukemia cutis in T-cell prolymphocytic leukemia.
    Khullar G; Singh S; Agrawal S; Sachdeva MU; Saikia UN
    Int J Dermatol; 2017 Mar; 56(3):e65-e67. PubMed ID: 28083939
    [No Abstract]   [Full Text] [Related]  

  • 8. Array comparative genomic hybridization in the detection of chromosomal abnormalities in T-cell prolymphocytic leukemia.
    Urbánková H; Holzerová M; Balcárková J; Raida L; Procházka V; Pikalová Z; Papajík T; Indrák K; Jarosová M
    Cancer Genet Cytogenet; 2010 Oct; 202(1):58-62. PubMed ID: 20804923
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia.
    Smith VM; Lomas O; Constantine D; Palmer L; Schuh AH; Bruce D; Gonchar O; Macip S; Jayne S; Dyer MJS; Eyre TA
    Blood Adv; 2020 Feb; 4(3):525-529. PubMed ID: 32040552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Gallipoli P; Clark A; Leach M
    Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of karyotyping,
    Sun Y; Tang G; Hu Z; Thakral B; Miranda RN; Medeiros LJ; Wang SA
    J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized pruritic dark papules in a patient with T-cell prolymphocytic leukemia - a clinicopathological challenge.
    Hu YQ; Hu J; Chen X; Zhang JZ
    Int J Dermatol; 2020 May; 59(5):e129-e130. PubMed ID: 31515798
    [No Abstract]   [Full Text] [Related]  

  • 13. [T-cell prolymphocytic leukemia revealed by spinal cord compression].
    Haouach K; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2013; 71(2):181-4. PubMed ID: 23587583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broken heart by T-prolymphocytic leukemia.
    Arranto C; Tzankov A
    Blood; 2017 Aug; 130(5):691. PubMed ID: 28775161
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell prolymphocytic leukemia presenting as ascites.
    Hermans SJF; Sandberg Y
    Blood; 2019 Jul; 134(4):411. PubMed ID: 31345928
    [No Abstract]   [Full Text] [Related]  

  • 16. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
    Cao TM; Coutre SE
    Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
    Yoshioka Y; Nagao M; Saitoh T; Yoshioka S; Tsunemine H; Itoh K; Kodaka T; Takahashi T
    J Clin Exp Hematop; 2015; 55(1):17-21. PubMed ID: 26106002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme hyperlymphocytosis.
    Berz D; Freeman NJ
    J Clin Oncol; 2008 Feb; 26(4):674-5. PubMed ID: 18235128
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.